Fluorescein versus Indocyanine Green Angiography Guided Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

被引:1
|
作者
Moodi, Farzan [1 ,2 ]
Naseripour, Masood [1 ,2 ,3 ]
Zand, Amin [1 ,2 ]
Mirshahi, Reza [1 ,2 ]
Moodi, Vihan [4 ]
Alemzadeh, Sayyed Amirpooya [1 ,2 ]
Falavarjani, Khalil Ghasemi [1 ,2 ,3 ,5 ]
机构
[1] Iran Univ Med Sci, Senses Hlth Inst 5, Eye Res Ctr, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[2] Iran Univ Med Sci, Senses Hlth Inst 5, Dept Ophthalmol, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[3] Iran Univ Med Sci, Stem Cell & Regenerat Med Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[5] Rassoul Akram Hosp, Eye Res Ctr, Sattarkhan Niaiesh St, Tehran 14456, Iran
关键词
Central Serous Chorioretinopathy; Fluorescein Angiography; Indocyanine Green Angiography; Photodynamic Therapy; VERTEPORFIN;
D O I
10.18502/jovr.v19i1.15420
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the outcomes of fluorescein angiography (FA)-guided and indocyanine green angiography (ICGA)-guided half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC). Methods: In this retrospective comparative study, medical records of eyes with chronic CSC who underwent half-dose PDT were reviewed. A retina specialist performed FA-guided half-dose PDT, and the other performed ICGA-guided treatment. The success of applying PDT in the resolution of subretinal fluid was compared between the FA- and ICGA-guided methods. Results: Eighty-two eyes of 73 patients (41 eyes in each group) received half-dose PDT. After halfdose PDT, a significant improvement in the best-corrected visual acuity (BCVA) was found at the time of the last follow-up in both groups (both P < 0.001), with no significant intergroup difference. Central subfield and subfoveal choroidal thicknesses decreased significantly in both groups at the last follow-up (all P < 0.05), with no significant differences between the groups. Subretinal fluid (SRF) resolved in all eyes, and no persistent SRF was detected during the follow-up period. Conclusion: FA-guided and ICG-guided half-dose PDT may have similar efficacy for the treatment of chronic CSC.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 50 条
  • [41] Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
    Ratanasukon, Mansing
    Thongthong, Koblarp
    Bhurayanontachai, Patama
    Jirarattanasopa, Pichai
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 87 - 92
  • [42] Half-Dose Verteporfin Photodynamic Therapy (hdPDT) in the Treatment of Central Serous Chorioretinopathy
    Hoehn, F.
    Kretz, F. T. A.
    Beger, I.
    Koch, F.
    Auffarth, G. U.
    Singh, P.
    Deuchler, S.
    Koss, M. J.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2016, 233 (07) : 860 - 863
  • [43] Indocyanine green angiography in chronic central serous chorioretinopathy
    Gajdzik-Gajdecka, Urszula
    Dorecka, Mariola
    Nita, Ewa
    Michalska, Anna
    Miniewicz-Kurkowska, Joanna
    Romaniuk, Wanda
    MEDICAL SCIENCE MONITOR, 2012, 18 (02): : CR51 - CR57
  • [44] Indocyanine green angiography-guided photodynamic therapy for chronic central serous chorioretinopathy: digital fundus camera versus scanning laser ophthalmoscope
    Lee, Seung Min
    Kwon, Hanjo
    Park, Sungwho
    Lee, Ji Eun E.
    Byon, Ik Soo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [45] Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
    Miao Zeng
    Xiao Chen
    Yanping Song
    Chunyan Cai
    BMC Ophthalmology, 22
  • [46] Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
    Zeng, Miao
    Chen, Xiao
    Song, Yanping
    Cai, Chunyan
    BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [47] Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy
    Yu-Te Huang
    Peng-Tai Tien
    Po-Yu Chen
    Chi-Lan Yang
    San-Ni Chen
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 1755 - 1763
  • [48] Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy A case report
    Zhang, Zhengwei
    Bao, Xiaona
    Wu, Zhifeng
    Zhang, Jie
    MEDICINE, 2021, 100 (07) : E24790
  • [49] Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy
    Huang, Yu-Te
    Tien, Peng-Tai
    Chen, Po-Yu
    Yang, Chi-Lan
    Chen, San-Ni
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (06) : 1755 - 1763
  • [50] Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
    Kinoshita, Takamasa
    Mitamura, Yoshinori
    Mori, Terumi
    Akaiwa, Kei
    Semba, Kentaro
    Egawa, Mariko
    Mori, Junya
    Sonoda, Shozo
    Sakamoto, Taiji
    PLOS ONE, 2016, 11 (09):